Search Results

Clinical and histopathological aspects of lichenoid dermatitis in patients of retroviral diseases

• Authors : Tambe, Swagata; Zambare, Uddhao; Nayak, Chitra

• Source: Indian Journal of Sexually Transmitted Diseases and AIDS. Jan-June, 2022, Vol. 43 Issue 1, 59

Record details

Studies from Chongqing Medical University Describe New Findings in Hepatitis B Virus (Adverse effect of paternal hepatitis B virus infection on clinical pregnancy after frozen-thawed embryo transfer).

• Source: Women's Health Weekly. 2018, pages. 6282

Record details

Data from Ain Shams University Provide New Insights into Hepatitis B Vaccines (High Risk of Hbv Infection Among Vaccinated Polytransfused Children With Malignancy).

• Source: Vaccine Weekly. 2021, pages. 162

Record details

Vir Biotechnology Presents New Clinical Data from Ongoing Trials of VIR-2218 and VIR-3434 in Patients with Chronic Hepatitis B Virus Infection at the International Liver Congress 2021.

• Source: Legal Monitor Worldwide. 2021.

Record details

Vir Biotechnology Presents New Clinical Data from Ongoing Trials of VIR-2218 and VIR-3434 in Patients with Chronic Hepatitis B Virus Infection at the International Liver Congress 2021.

• Source: Contify Life Science News. 2021.

Record details

Recent Findings in Hepatitis B Virus Described by Dinamene Oliveira and Colleagues (A systematic review of the maternal and neonatal complications in hepatitis B infection).

• Source: OBGYN & Reproduction Week. 2020, pages. 458

Record details

Disease burden of chronic hepatitis B and complications in China from 2006 to 2050: an individual-based modeling study.

• Authors : Zheng, Yang; Wu, Jie; Ding, Cheng

• Source: Virology Journal. August 28, 2020, Vol. 17 Issue 1.

Record details

A Spatial Whole-Cell Model for HBV Viral Infection and Drug Interactions

• Source: Gastroenterology Week. June 13, 2022, 101

Record details

Gilead Presents Data at the International Liver Congress 2017 Supporting the Efficacy and Safety of Vemlidy in Patients with Chronic Hepatitis B After 96 Weeks, and Also After Switching From Viread.

• Source: Plus Company Updates. 2017.

Record details

Gilead Presents Data at the International Liver Congress 2017 Supporting the Efficacy and Safety of Vemlidy in Patients with Chronic Hepatitis B After 96 Weeks, and Also After Switching From Viread.

• Source: India Pharma News. 2017.

Record details